Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
466 One study proposed a novel mechanism wherein postprandial GLP-1 release, under normal physiological conditions, inhibits the activity of chemosensory cells in the carotid body, thereby counteracting sympathetic excitability mediated by elevated blood glucose or insulin levels
The GLP-1 released into the body after eating is mostly stored in L cells, or intestinal endocrine cells
The peptide aids wound healing and reduces inflammation, which may reduce the harmful effects of UV exposure (1)
PLoS ONE, 5 (1), e8976
It is important to note that, unlike several other pharmaceutical chemicals, BV active ingredients possess the ability to cross the blood-brain barrier, making them a potentially feasible approach for the management of CNS disorders in coming years
20000839, Proteintech, China)
US$ 27.53
US$ 24.96
US$ 26.40
